Particle Therapy 2017
• In design-phase: The PC05 neoadjuvant protocol (preopera3vely) for pa3ents with resectable and marginally resectable cancers. Randomiza3on between: – 59.40CGE to gross disease – 50.40CGE to regional nodes with a gross disease boost to 59.40CGE C. Nichols – cont.:
Made with FlippingBook flipbook maker